HIGHLIGHTED STORIES: New Blood Test Marks a Breakthrough in the Diagnosis of Bowel Cancer

2 Mar

New Blood Test Marks a Breakthrough in the Diagnosis of Bowel Cancer

 

The simple check will pick up on antibodies in the blood, produced as the body reacts to the onset of bowel cancer. The collaboration between researchers from the Biomedical Diagnostics Institute at Dublin City Universityand Irish biotech firm Randox promises that the new test may be a significant breakthrough in the diagnosis of bowel cancer.  Studies show that the identification of these very specific biomarkers will allow for a test which is more sensitive and accurate than existing screening. The new blood test may do away with the need for Fecal Occult Blood Test, which has relatively low sensitivity and a high level of patient reluctance, and will prevent unnecessary and costly colonoscopies for people without the disease. The new test will be implemented on Randox’s proprietary Biochip Array Technology detection platform.    Source: http://www.mlo-online.com/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: